Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy

Sponsor
Germans Trias i Pujol Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03160690
Collaborator
Pau Romera Romero (Other), Jorge Loscos Arenas (Other), Nevena Romanic Bubalo (Other), Jordi Castellví Manent (Other)
20
1
11
1.8

Study Details

Study Description

Brief Summary

Prospective and observational study to determine if choroidal thickness increases after non penetrating deep sclerectomy in patients with open angle glaucoma

Condition or Disease Intervention/Treatment Phase
  • Procedure: Non penetrating deep sclerectomy

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy
Anticipated Study Start Date :
Jun 17, 2017
Anticipated Primary Completion Date :
Nov 17, 2017
Anticipated Study Completion Date :
May 17, 2018

Outcome Measures

Primary Outcome Measures

  1. Change in Choroidal thickness [before and 1 week, 1 month, 3 months and 6 months after non penetrating deep sclerectomy]

    Choroidal thickness measured by optic coherence tomography

  2. Change in Intraocular pressure [before and 1 week, 1 month, 3 months and 6 months after non penetrating deep sclerectomy]

    mmHg

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Progressive Primary Open Angle Glaucoma
Exclusion Criteria:
  • Age under 18yrs

  • Myopia or Hyperopia higher than -6D or +6D

  • Secondary glaucoma

  • Ocular surgery other than cataract

  • Other ocular pathology

Contacts and Locations

Locations

Site City State Country Postal Code
1 Germans Trias i Pujol Hospital Badalona Barcelona Spain 08916

Sponsors and Collaborators

  • Germans Trias i Pujol Hospital
  • Pau Romera Romero
  • Jorge Loscos Arenas
  • Nevena Romanic Bubalo
  • Jordi Castellví Manent

Investigators

  • Principal Investigator: Sandra Gómez Sánchez, MD, Germans Trias i Pujol Hospital
  • Principal Investigator: Pau Romera Romero, MD, Germans Trias i Pujol Hospital
  • Principal Investigator: Jorge Loscos Arenas, PhD, Germans Trias i Pujol Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sandra Gómez Sánchez, Principal Investigator, Germans Trias i Pujol Hospital
ClinicalTrials.gov Identifier:
NCT03160690
Other Study ID Numbers:
  • OFT-ENP-2017-03
First Posted:
May 19, 2017
Last Update Posted:
May 19, 2017
Last Verified:
May 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sandra Gómez Sánchez, Principal Investigator, Germans Trias i Pujol Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2017